<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article  PUBLIC "-//NLM//DTD Journal Publishing DTD v3.0 20080202//EN" "http://dtd.nlm.nih.gov/publishing/3.0/journalpublishing3.dtd"><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="3.0" xml:lang="en" article-type="research article"><front><journal-meta><journal-id journal-id-type="publisher-id">JBM</journal-id><journal-title-group><journal-title>Journal of Biosciences and Medicines</journal-title></journal-title-group><issn pub-type="epub">2327-5081</issn><publisher><publisher-name>Scientific Research Publishing</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.4236/jbm.2023.118008</article-id><article-id pub-id-type="publisher-id">JBM-127065</article-id><article-categories><subj-group subj-group-type="heading"><subject>Articles</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Biomedical&amp;Life Sciences</subject></subj-group></article-categories><title-group><article-title>
 
 
  Altered Liver Gene Expression Due to Hypertension and Age in Rats
 
</article-title></title-group><contrib-group><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>María</surname><given-names>Dolores Ronquillo-Sánchez</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Jorge</surname><given-names>Ramírez-Salcedo</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Itzell</surname><given-names>Alejandrina Gallardo-Ortíz</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author" xlink:type="simple"><name name-style="western"><surname>Rafael</surname><given-names>Villalobos-Molina</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref><xref ref-type="corresp" rid="cor1"><sup>*</sup></xref></contrib></contrib-group><aff id="aff1"><addr-line>Unidad de Biomedicina, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla, México</addr-line></aff><aff id="aff3"><addr-line>Carrera de Enfermería, Facultad de Estudios Superiores Iztacala, Universidad Nacional Autónoma de México, Tlalnepantla, México</addr-line></aff><aff id="aff2"><addr-line>Departamento de Biología Celular y del Desarrollo, Instituto de Fisiología Celular, Universidad Nacional Autónoma de México, Ciudad de México, México</addr-line></aff><pub-date pub-type="epub"><day>04</day><month>08</month><year>2023</year></pub-date><volume>11</volume><issue>08</issue><fpage>82</fpage><lpage>94</lpage><history><date date-type="received"><day>15,</day>	<month>July</month>	<year>2023</year></date><date date-type="rev-recd"><day>15,</day>	<month>August</month>	<year>2023</year>	</date><date date-type="accepted"><day>18,</day>	<month>August</month>	<year>2023</year></date></history><permissions><copyright-statement>&#169; Copyright  2014 by authors and Scientific Research Publishing Inc. </copyright-statement><copyright-year>2014</copyright-year><license><license-p>This work is licensed under the Creative Commons Attribution International License (CC BY). http://creativecommons.org/licenses/by/4.0/</license-p></license></permissions><abstract><p>
 
 
  Hypertension and metabolic syndrome, both of which increase with age, are multifactorial disorders. Their etiology is complex, making it challenging to isolate involved genes. This study aimed to characterize the hepatic gene expression in spontaneously hypertensive rats (SHR) at different ages. Blood pressure in SHR was determined by tail-cuff method at one and three months of age. Hepatic RNA was isolated and gene expression was compared using microarrays. Comparison between SHR and normotensive rats revealed significant variation in gene expression: 98 genes were upregulated and 122 were downregulated in SHR; while 88 genes were upregulated and 139 genes were downregulated in age-matched normotensive rats. Furthermore, within the SHR group, 110 genes were found to be upregulated and 168 genes downregulated across different ages. Analyses via the Gene Ontology, and Kyoto Encyclopedia of Genes and Genomes pathways revealed that several genes are potentially implicated in both, hypertension and metabolic syndrome. The results suggest that SHR display variations in gene expression due to aging, and when compared to normotensive rats. These variations could contribute to the development of hypertension and metabolic syndrome. Microarray studies involving older rats are necessary to further validate these findings.
 
</p></abstract><kwd-group><kwd>Hypertension</kwd><kwd> Metabolic Syndrome</kwd><kwd> Gene Expression</kwd><kwd> SHR</kwd><kwd> Microarray</kwd></kwd-group></article-meta></front><body><sec id="s1"><title>1. Introduction</title><p>Hypertension and metabolic syndrome (MetS) are diseases of multifactorial origin, that significantly contribute to high morbidity and mortality around the world [<xref ref-type="bibr" rid="scirp.127065-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.127065-ref2">2</xref>] . MetS is characterized by central obesity, impairment of lipid metabolism, hyperglycemia/insulin resistance, and hypertension [<xref ref-type="bibr" rid="scirp.127065-ref3">3</xref>] . Primary hypertension, a component of MetS, is prevalent globally and is a major factor risk for cardiovascular diseases (CVDs) [<xref ref-type="bibr" rid="scirp.127065-ref4">4</xref>] . Hypertension involves abnormal responses in the central nervous, cardiovascular, and renal systems. In contrast, MetS is a cluster of metabolic and cardiovascular symptoms, including hyperglycemia, abdominal obesity, dyslipidemia, and dysfunctions of the liver, pancreas, and adipose tissue [<xref ref-type="bibr" rid="scirp.127065-ref5">5</xref>] . Both MetS and hypertension are known to increase with age, leading to the common perception of these conditions as age-related disorders [<xref ref-type="bibr" rid="scirp.127065-ref2">2</xref>] [<xref ref-type="bibr" rid="scirp.127065-ref6">6</xref>] [<xref ref-type="bibr" rid="scirp.127065-ref7">7</xref>] .</p><p>In recent years there have been significant advances in genetic mapping of both hypertension and MetS [<xref ref-type="bibr" rid="scirp.127065-ref1">1</xref>] [<xref ref-type="bibr" rid="scirp.127065-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.127065-ref9">9</xref>] [<xref ref-type="bibr" rid="scirp.127065-ref10">10</xref>] [<xref ref-type="bibr" rid="scirp.127065-ref11">11</xref>] . However, the multifactorial nature of these conditions complicates to isolate genes involved in their etiology. To address this, two approaches have proven valuable in the search for underlying diseases factors: 1) due to their similar pathophysiology, spontaneously hypertensive rats (SHR) serve as a widely used animal model for human primary hypertension and metabolic syndrome [<xref ref-type="bibr" rid="scirp.127065-ref12">12</xref>] [<xref ref-type="bibr" rid="scirp.127065-ref13">13</xref>] [<xref ref-type="bibr" rid="scirp.127065-ref14">14</xref>] [<xref ref-type="bibr" rid="scirp.127065-ref15">15</xref>] [<xref ref-type="bibr" rid="scirp.127065-ref16">16</xref>] ; and 2) microarrays, a robust methodology for study expression of thousands of genes in a single experiment [<xref ref-type="bibr" rid="scirp.127065-ref8">8</xref>] [<xref ref-type="bibr" rid="scirp.127065-ref16">16</xref>] [<xref ref-type="bibr" rid="scirp.127065-ref17">17</xref>] , allow for the comprehensive analysis of gene expression in these models of hypertension/MetS. This understanding of the expression in SHRs can provide useful information about genes and pathways related to pathophysiological traits in humans. Prompted by these insights, we aimed to characterize the gene expression profiles of SHR liver at different stages of hypertension.</p></sec><sec id="s2"><title>2. Materials and Methods</title><sec id="s2_1"><title>2.1. Animals and Ethical Statement</title><p>Male spontaneously hypertensive rats (SHR, aged 1 month as prehypertensive stage, and 3 months as hypertensive stage, n = 2), and Wistar Kyoto rats (WKY, aged 1 month, and 3 months, both ages as normotensive stage, n = 2), used as a control group, were obtained from the animal facility of the Institute of Cell Physiology at the National Autonomous University of Mexico. All animal housing, care, and procedures were conducted in accordance with Mexican Regulations for Animal Care and Use (NOM-062-ZOO-1999, SAGARPA, Mexico), and the Guide for the Care and Use of Laboratory Animals, as promulgated by the U.S. National Institutes of Health (8<sup>th</sup> edition, 2011). Animals were maintained in a pathogen-free environment under controlled conditions (22˚C &#177; 2˚C, 40% - 60% humidity, 12 hours light/12 hours dark cycle), with free access to tap water, and fed a standard rat chow ad libitum throughout the experimental periods, except during the overnight (12 - 16 h) fasting period before being euthanized. All experimental protocols were approved by the Ethics Committee of the Facultad de Estudios Superiores Iztacala, Universidad Nacional Aut&#243;noma de M&#233;xico (Protocol number 1368).</p></sec><sec id="s2_2"><title>2.2. Procedures</title><sec id="s2_2_1"><title>2.2.1. Measurement of Blood Pressure in SHR and WKY Rats</title><p>The indirect measurement of blood pressure was carried out using a tail-cuff device (Automatic Blood Pressure Computer, Model LE 5007; Letica, Panlab, Spain), as described previously [<xref ref-type="bibr" rid="scirp.127065-ref18">18</xref>] . Briefly, rats were gently restrained in a size-appropriate plastic container. A blood pressure transducer and a ring containing inflatable latex were placed on the tail, while the rat was kept warm within the device (35˚C - 37˚C). The rats were trained to remain inside the container with the cuff on the tail, and to tolerate inflation and deflation of the latex ring (this process was repeated several times beforehand). Each rat then underwent a minimum of three blood pressure measurements. This procedure was conducted between 8 and 10 AM.</p></sec><sec id="s2_2_2"><title>2.2.2. Tissue Collection</title><p>Rats were sacrificed by cervical dislocation, after which their livers were rapidly removed, rinsed in phosphate buffer solution at 4˚C, and frozen in cryogenic vials at −80˚C until RNA extraction.</p></sec><sec id="s2_2_3"><title>2.2.3. RNA Isolation</title><p>Total RNA was extracted from 50 mg of the frozen livers’ samples using Trizol reagent (Invitrogen Life Technologies, Carlsbad, CA, USA), as per the manufacturer’s protocol. The concentration and purity of the total RNA were determined spectrophotometrically at 260/280 nm using an Agilent<sup>TM</sup> Bioanalyzer (Agilent Technologies, Palo Alto, CA, USA), ensuring all ratios exceeded 1.8. The integrity of the RNA was confirmed through electrophoresis on a 1.5% denaturing agarose gel.</p></sec><sec id="s2_2_4"><title>2.2.4. Gene Expression Profiling in SHR and WKY Rats</title><p>Gene expression in liver samples from SHR and WKY rats was analyzed using rat microarrays. Three independent experiments were conducted: the first microarray compared the gene expression profile of 1-month-old SHR with age-matched WKY; the second microarray compared the gene expression profile of 3-month-old SHR with age-matched WKY; and the third microarray compared the gene expression profile of 1-month-old with 3-month-old SHR.</p></sec><sec id="s2_2_5"><title>2.2.5. Arrays Printing</title><p>The Rattus norvegicus 70-mer oligo library from OPERON Oligo Sets (http://omad.operon.com/), containing 5000 gene-specific oligonucleotide probes representing the better-known genes, were suspended in 40 μM of Micro Spotting solution (TeleChem International Inc., Portland, OR, USA). SuperAmine-coated slides (25 &#215; 75 mm, TeleChem) were printed in duplicate and fixed at 80˚C for 4 hours. For pre-hybridization, the slides were re-hydrated with water vapor at 60˚C, then fixed with two cycles of UV light (1200J). After being boiled for 2 min at 92˚C, the slides were washed with 95% ethanol for 1 min and pre-hybridized in 5X SSC, 0.1% SDS, and 1% BSA for 1 hour at 42˚C. The slides were then washed and dried for further hybridization.</p></sec><sec id="s2_2_6"><title>2.2.6. Probe Preparation and Hybridization to Arrays</title><p>Ten μg of total RNA were used for complementary DNA (cDNA) synthesis, which incorporated dUTP-Alexa555 or dUTP-Alexa647, employing the First-Strand cDNA Labeling Kit (Invitrogen). The incorporation of a fluorophore was analyzed by measuring the absorbance at 555 nm for Alexa555, and 650 nm for Alexa647. Equal quantities of labeled cDNA were hybridized using the UniHyb hybridization solution (TeleChem). The arrays were incubated for 14 h at 42˚C, then washed three times with 1X SCC and 0.05% SDS at room temperature.</p></sec><sec id="s2_2_7"><title>2.2.7. Data Acquisition and Analysis of Array Images</title><p>The acquisition and quantification of array images were performed on a GenePix 4100A with its accompanying software, GenePix (Molecular Devices, Sunnyvale, CA, USA); all images were captured at a resolution of 10 μm. For each spot, the Alexa555 and Alexa647 density mean values, as well as the background mean values, were calculated using the ArrayPro Analyzer software (Media Cybernetics, Rockville, MD, USA).</p></sec><sec id="s2_2_8"><title>2.2.8. Functional Analysis by Gene Ontology and Gene Pathways</title><p>Microarray data analysis was carried out using the genArise software, developed in our Informatics Unit (http://www.ifc.unam.mx/genarise/). GenArise performs several operations, including background correction, lowess normalization, intensity filtering, replicates analysis, and selecting differentially expressed genes. The goal of genArise is to identify genes that show substantial evidence of differential expression. The Database for Annotation, Visualization, and Integrated Discovery (DAVID Bioinformatics database) was employed to identify functionally related genes categories. Differentially expressed genes were considered significant and selected based on a change in expression of at least 1.5-fold, and a p-value of ≤0.05. The DAVID software analyzed significant enrichment of differentially expressed genes within Gene Ontology (GO) terms, and involves assessment of advanced pathway analysis [<xref ref-type="bibr" rid="scirp.127065-ref19">19</xref>] . Biological pathways were obtained from Kyoto Encyclopedia of Genes and Genomes (KEGG) [<xref ref-type="bibr" rid="scirp.127065-ref20">20</xref>] . KEGG pathway analysis (http://www.kegg.jp/kegg/docs/statistics.html) is a comprehensive pathway prediction tool that contains &gt;200 pathways, and a collection of pathway maps representing molecular interaction and reaction networks for sequences. The microarray dataset has been deposited in the NCBI Gene Expression Omnibus (GEO) public database in compliance with MIAME (Minimum Information About a Microarray Experiment) guidelines (GEO series accession number GSE96587).</p></sec></sec><sec id="s2_3"><title>2.3. Statistical Analysis</title><p>Statistical analysis was performed using commercially available GraphPad Prism version 4.0 software (La Jolla, CA, USA). The data are expressed as the mean &#177; SEM. Statistical significance was determined using Student’s t-test, with the significance set at p ≤ 0.05.</p></sec></sec><sec id="s3"><title>3. Results</title><sec id="s3_1"><title>3.1. Body Weight Measurement in SHR and WKY Rats</title><p>The body weights were 83 &#177; 1.9 g in WKY vs. 64.7 &#177; 1.3 g in SHR at 1-month-old (p ≤ 0.05), while 310.1 &#177; 3.3 g in WKY vs. 251.9 &#177; 4 g in SHR at 3-month-old (p ≤ 0.05).</p></sec><sec id="s3_2"><title>3.2. Systolic Blood Pressure in SHR and WKY Rats</title><p>The systolic blood pressure of SHR was similar to that of WKY rats at 1 month-old (113 &#177; 2 mmHg in WKY vs. 112 &#177; 3 mmHg in SHR at pre-hypertensive stage). However, it was higher at 3-month-old (112 &#177; 3 mmHg in WKY vs. 184 &#177; 4 mmHg in SHR at the hypertensive stage). Blood pressure increased in SHR from 1- to 3-month-old (p ≤ 0.5), whereas it did not change with age in WKY. The study model (SHR) emulates the phenomenon observed in humans, where blood pressure increases with age.</p></sec><sec id="s3_3"><title>3.3. Gene Expression Profiles in SHR and WKY Rats</title><p>Three independent microarray analyses were performed. The first examined gene expression in the liver of 1-month-old SHR vs. age-matched WKY. The second assessed the gene expression of 3-month-old SHR vs. age-matched WKY. The third compared the gene expression profile of 1-month-old vs. 3-month-old SHR. The hierarchical clusters show the differential expression of all the transcripts; a color scale is included with the heat map to visualize the consistency of the expression patterns within each group of samples (<xref ref-type="fig" rid="fig1">Figure 1</xref>(a)), as well as the difference between groups (WKY vs. SHR). Additionally, a Venn diagram shows the total number of genes regulated up and down in the different microarrays and the number of common genes found (<xref ref-type="fig" rid="fig1">Figure 1</xref>(b)).</p></sec><sec id="s3_4"><title>3.4. Microarrays Gene Ontology and Gene Pathways</title><p>Data from the microarrays were analyzed using the DAVID database software to identify genes differentially expressed in SHR, compared with WKY at both ages (p ≤ 0.05). All identified differences are shown in <xref ref-type="table" rid="table1">Table 1</xref> and <xref ref-type="table" rid="table2">Table 2</xref>.</p><p>Pathway analysis was conducted through the DAVID bioinformatics database to identify biological processes. The most enriched databases of pathways from our study were obtained through KEGG, as shown in <xref ref-type="table" rid="table3">Table 3</xref>.</p><p>Gene Ontology enrichment analysis is based on the knowledge of various biological elements, and KEGG annotations contain information on more than 200 pathways. The identified GO functions were predominantly associated with adrenergic signaling, renin secretion, aldosterone synthesis and secretion, and calcium signaling in SHR rats. The KEGG pathway analysis revealed differentially expressed genes highlighted with red stars, as demonstrated in a representative selected pathway, i.e., aldosterone synthesis and secretion (<xref ref-type="fig" rid="fig2">Figure 2</xref>).</p><table-wrap id="table1" ><label><xref ref-type="table" rid="table1">Table 1</xref></label><caption><title> Differentially expressed gene transcripts in the liver of 1- and 3-month-old SHR vs. age-matched WKY</title></caption><table><tbody><thead><tr><th align="center" valign="middle" >Number of genes</th><th align="center" valign="middle" >1 month-old</th><th align="center" valign="middle" >3 month-old</th><th align="center" valign="middle" >Common in both</th></tr></thead><tr><td align="center" valign="middle" >Up-regulated</td><td align="center" valign="middle" >98</td><td align="center" valign="middle" >88</td><td align="center" valign="middle" >12</td></tr><tr><td align="center" valign="middle" >Down-regulated</td><td align="center" valign="middle" >122</td><td align="center" valign="middle" >139</td><td align="center" valign="middle" >10</td></tr><tr><td align="center" valign="middle" >Total</td><td align="center" valign="middle" >220</td><td align="center" valign="middle" >227</td><td align="center" valign="middle" >22</td></tr></tbody></table></table-wrap><p>p ≤ 0.05, fold change ≤1.5 or &gt;1.5.</p><table-wrap id="table2" ><label><xref ref-type="table" rid="table2">Table 2</xref></label><caption><title> Differentially expressed gene transcripts in the liver of 1-month-old vs. 3-month-old SHR</title></caption>
</table-wrap>
</sec></sec>
</body>

<back><ref-list><title>References</title><ref id="scirp.127065-ref1"><label>1</label><mixed-citation publication-type="other" xlink:type="simple">Brown, A.E. and Walker, M. (2016) Genetics of Insulin Resistance and the Metabolic Syndrome. Current Cardiology Reports, 18, Article No. 75. https://doi.org/10.1007/s11886-016-0755-4</mixed-citation></ref><ref id="scirp.127065-ref2"><label>2</label><mixed-citation publication-type="other" xlink:type="simple">WHO (2013) WHO: A Global Brief on Hypertension. Silent Killer, Global Public Health Crisis. https://apps.who.int/iris/handle/10665/79059</mixed-citation></ref><ref id="scirp.127065-ref3"><label>3</label><mixed-citation publication-type="other" xlink:type="simple">Alberti, K.G., Eckel, R.H., Grundy, S.M., et al. (2009) Harmonizing the Metabolic Syndrome: A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; International Association for the Study of Obesity. Circulation, 120, 1640-1645. https://doi.org/10.1161/CIRCULATIONAHA.109.192644</mixed-citation></ref><ref id="scirp.127065-ref4"><label>4</label><mixed-citation publication-type="other" xlink:type="simple">Petrie, J.R., Guzik, T.J. and Touyz, R.M. (2018) Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Canadian Journal of Cardiology, 34, 575-584. https://doi.org/10.1016/j.cjca.2017.12.005</mixed-citation></ref><ref id="scirp.127065-ref5"><label>5</label><mixed-citation publication-type="other" xlink:type="simple">Mendizabal, Y., Llorens, S. and Nava, E. (2013) Hypertension in Metabolic Syndrome: Vascular Pathophysiology. International Journal of Hypertension, 2013, Article ID: 230868. https://doi.org/10.1155/2013/230868</mixed-citation></ref><ref id="scirp.127065-ref6"><label>6</label><mixed-citation publication-type="other" xlink:type="simple">Bonomini, F., Rodella, L.F. and Rezzani, R. (2015) Metabolic Syndrome, Aging and Involvement of Oxidative Stress. Aging and Disease, 6, 109-120. https://doi.org/10.14336/AD.2014.0305</mixed-citation></ref><ref id="scirp.127065-ref7"><label>7</label><mixed-citation publication-type="other" xlink:type="simple">Dominguez, L.J. and Barbagallo, M. (2016) The Biology of the Metabolic Syndrome and Aging. Current Opinion in Clinical Nutrition and Metabolic Care, 19, 5-11. https://doi.org/10.1097/MCO.0000000000000243</mixed-citation></ref><ref id="scirp.127065-ref8"><label>8</label><mixed-citation publication-type="other" xlink:type="simple">Atanur, S.S., Birol, I., Guryev, V., et al. (2010) The Genome Sequence of the Spontaneously Hypertensive Rat: Analysis and Functional Significance. Genome Research, 20, 791-803. https://doi.org/10.1101/gr.103499.109</mixed-citation></ref><ref id="scirp.127065-ref9"><label>9</label><mixed-citation publication-type="other" xlink:type="simple">Chang, Y., Yu, Y. and Chuang, L. (2013) Molecular Genetics of Metabolic Syndrome. Encyclopedia of Life Sciences (ELS). Wiley-Blackwell, Berlin. https://doi.org/10.1002/9780470015902.a0024320</mixed-citation></ref><ref id="scirp.127065-ref10"><label>10</label><mixed-citation publication-type="other" xlink:type="simple">Taylor, J.Y., Kraja, A.T., de Las Fuentes, L., et al. (2013) An Overview of the Genomics of Metabolic Syndrome. Journal of Nursing Scholarship, 45, 52-59. https://doi.org/10.1111/j.1547-5069.2012.01484.x</mixed-citation></ref><ref id="scirp.127065-ref11"><label>11</label><mixed-citation publication-type="book" xlink:type="simple">Yang, P. (2012) Differential Gene Expression Profile in Essential Hypertension. In: Khullar, M., Ed., Genetics and Pathophysiology of Essential Hypertension, IntechOpen, London, 211-218. https://doi.org/10.5772/29645</mixed-citation></ref><ref id="scirp.127065-ref12"><label>12</label><mixed-citation publication-type="other" xlink:type="simple">Aleixandre de Artinano, A. and Castro M. (2009) Experimental Rat Models to Study the Metabolic Syndrome. British Journal of Nutrition, 102, 1246-1253. https://doi.org/10.1017/S0007114509990729</mixed-citation></ref><ref id="scirp.127065-ref13"><label>13</label><mixed-citation publication-type="other" xlink:type="simple">Chang, J., Oikawa, S., Ichihara, G., et al. (2012) Altered Gene and Protein Expression in Liver of the Obese Spontaneously Hypertensive/NDmcr-cp Rat. Nutrition and Metabolism (London), 9, Article No. 87.https://doi.org/10.1186/1743-7075-9-87</mixed-citation></ref><ref id="scirp.127065-ref14"><label>14</label><mixed-citation publication-type="other" xlink:type="simple">Coan, P.M., Hummel, O., Garcia Diaz, A., et al. (2017) Genetic, Physiological and Comparative Genomic Studies of Hypertension and Insulin Resistance in the Spontaneously Hypertensive Rat. Disease Models and Mechanisms, 10, 297-306. https://doi.org/10.1242/dmm.026716</mixed-citation></ref><ref id="scirp.127065-ref15"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">Oron-Herman, M., Kamari, Y., Grossman, E., et al. (2008) Metabolic Syndrome: Comparison of the Two Commonly Used Animal Models. American Journal of Hypertension, 21, 1018-1022. https://doi.org/10.1038/ajh.2008.218</mixed-citation></ref><ref id="scirp.127065-ref16"><label>16</label><mixed-citation publication-type="other" xlink:type="simple">Yamamoto, H., Okuzaki, D., Yamanishi, K., et al. (2013) Genetic Analysis of Genes Causing Hypertension and Stroke in Spontaneously Hypertensive Rats. International Journal of Molecular Medicine, 31, 1057-1065. https://doi.org/10.3892/ijmm.2013.1304</mixed-citation></ref><ref id="scirp.127065-ref17"><label>17</label><mixed-citation publication-type="other" xlink:type="simple">Delles, C., McBride, M.W., Graham, D., et al. (2010) Genetics of Hypertension: From Experimental Animals to Humans. Biochimica et Biophysica Acta, 1802, 1299-1308. https://doi.org/10.1016/j.bbadis.2009.12.006</mixed-citation></ref><ref id="scirp.127065-ref18"><label>18</label><mixed-citation publication-type="other" xlink:type="simple">Gallardo-Ortíz, I.A., Rodríguez-Hernández, S.N., López-Guerrero, J.J., et al. (2016) Role of Alpha1D-Adrenoceptors in Vascular Wall Hypertrophy during Angiotensin II-Induced Hypertension. Autonomic &amp; Autacoid Pharmacology, 35, 17-31. https://doi.org/10.1111/aap.12035</mixed-citation></ref><ref id="scirp.127065-ref19"><label>19</label><mixed-citation publication-type="other" xlink:type="simple">Huang, D.W., Sherman, B.T. and Lempicki, R.A. (2009) Systematic and Integrative Analysis of Large Gene Lists Using DAVID Bioinformatics Resources. Nature Protocols, 4, 44-57. https://doi.org/10.1038/nprot.2008.211</mixed-citation></ref><ref id="scirp.127065-ref20"><label>20</label><mixed-citation publication-type="other" xlink:type="simple">Kanehisa, M., Goto, S., Sato, Y., et al. (2012) KEGG for Integration and Interpretation of Large-Scale Molecular Data Sets. Nucleic Acids Research, 40, D109-D114. https://doi.org/10.1093/nar/gkr988</mixed-citation></ref><ref id="scirp.127065-ref21"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Sun, Z. (2015) Aging, Arterial Stiffness, and Hypertension. Hypertension, 5, 252-256. https://doi.org/10.1161/HYPERTENSIONAHA.114.03617</mixed-citation></ref><ref id="scirp.127065-ref22"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">Svoboda, D.S. and Kawaja, M.D. (2012) Changes in Hepatic Protein Expression in Spontaneously Hypertensive Rats Suggest Early Stages of Non-Alcoholic Fatty Liver Disease. Journal of Proteomics, 75, 1752-1763. https://doi.org/10.1016/j.jprot.2011.12.011</mixed-citation></ref><ref id="scirp.127065-ref23"><label>23</label><mixed-citation publication-type="other" xlink:type="simple">Rodríguez, J.E., Saucedo-Campos, A.D., Ramírez-Hernández, D., et al. (2020) Myocardial Remodeling in Spontaneously Hypertensive Rats: The Role of α1D-Adrenergic Receptors. Journal of Hypertension, 38, 1496-1503. https://doi.org/10.1097/HJH.0000000000002412</mixed-citation></ref><ref id="scirp.127065-ref24"><label>24</label><mixed-citation publication-type="other" xlink:type="simple">Carey, R.M. (2015) The Intrarenal Renin-Angiotensin System in Hypertension. Advances in Chronic Kidney Disease, 22, 204-210. https://doi.org/10.1053/j.ackd.2014.11.004</mixed-citation></ref><ref id="scirp.127065-ref25"><label>25</label><mixed-citation publication-type="other" xlink:type="simple">Kumar, R., Thomas, C.M., Yong, Q.C., et al. (2012) The Intracrine Renin-Angiotensin System. Clinical Science (London), 123, 73-284. https://doi.org/10.1042/CS20120089</mixed-citation></ref><ref id="scirp.127065-ref26"><label>26</label><mixed-citation publication-type="other" xlink:type="simple">Ahmadian, E., Pennefather, P.S., Eftekhari, A., et al. (2016) Role of Renin-Angiotensin System in Liver Diseases: An Outline on the Potential Therapeutic Points of Intervention. Expert Review of Gastroenterology &amp; Hepatology, 10, 1279-1288. https://doi.org/10.1080/17474124.2016.1207523</mixed-citation></ref><ref id="scirp.127065-ref27"><label>27</label><mixed-citation publication-type="other" xlink:type="simple">Moreira de Macedo, S., Guimaraes, T.A., Feltenberger, J.D., et al. (2014) The Role of Renin-Angiotensin System Modulation on Treatment and Prevention of Liver Diseases. Peptides, 62, 189-196. https://doi.org/10.1016/j.peptides.2014.10.005</mixed-citation></ref><ref id="scirp.127065-ref28"><label>28</label><mixed-citation publication-type="other" xlink:type="simple">Lubel, J.S., Herath, C.B., Burrell, L.M., et al. (2008) Liver Disease and the Renin-Angiotensin System: Recent Discoveries and Clinical Implications. Journal of Gastroenterology and Hepatology, 23, 1327-1338. https://doi.org/10.1111/j.1440-1746.2008.05461.x</mixed-citation></ref><ref id="scirp.127065-ref29"><label>29</label><mixed-citation publication-type="other" xlink:type="simple">Pereira, R.M., dos Santos, R.A., da Costa Dias, F.L., et al. (2009) Renin-Angiotensin System in the Pathogenesis of Liver Fibrosis. World Journal of Gastroenterology, 15, 2579-2586. https://doi.org/10.3748/wjg.15.2579</mixed-citation></ref><ref id="scirp.127065-ref30"><label>30</label><mixed-citation publication-type="other" xlink:type="simple">Bollag, W.B. (2014) Regulation of Aldosterone Synthesis and Secretion. Comprehensive Physiology, 4, 1017-1055. https://doi.org/10.1002/cphy.c130037</mixed-citation></ref><ref id="scirp.127065-ref31"><label>31</label><mixed-citation publication-type="other" xlink:type="simple">Shi, Y., Shu, Z.J., Wang, H., et al. (2018) Altered Expression of Hepatic β-Adrenergic Receptors in Aging Rats: Implications for Age-Related Metabolic Dysfunction in Liver. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 314, R574-R583. https://doi.org/10.1152/ajpregu.00372.2017</mixed-citation></ref><ref id="scirp.127065-ref32"><label>32</label><mixed-citation publication-type="other" xlink:type="simple">Shidlovskyi, V.O., Shidlovskyi, O.V., Tovkai, O.A., et al. (2019) Topical Diagnosis and Determination of the Primary Hyperaldosteronism Variant. Journal of Medicine and Life, 12, 322-328. https://doi.org/10.25122/jml-2019-0072</mixed-citation></ref><ref id="scirp.127065-ref33"><label>33</label><mixed-citation publication-type="other" xlink:type="simple">Ghosh, P.M., Shu, Z.J., Zhu, B., et al. (2012) Role of β-Adrenergic Receptors in Regulation of Hepatic Fat Accumulation during Aging. Journal of Endocrinology, 213, 251-261. https://doi.org/10.1530/JOE-11-0406</mixed-citation></ref><ref id="scirp.127065-ref34"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Muscogiuri, G., Kamat, A., Balas, B., et al. (2011) β-Adrenergic Responsive Induction of Insulin Resistance in Liver of Aging Rats. Endocrine Research, 36, 74-82. https://doi.org/10.3109/07435800.2010.539993</mixed-citation></ref><ref id="scirp.127065-ref35"><label>35</label><mixed-citation publication-type="other" xlink:type="simple">Fan, F., Muroya, Y. and Roman, R.J. (2015) Cytochrome P450 Eicosanoids in Hypertension and Renal Disease. Current Opinion in Nephrology and Hypertension, 24, 37-46. https://doi.org/10.1097/MNH.0000000000000088</mixed-citation></ref><ref id="scirp.127065-ref36"><label>36</label><mixed-citation publication-type="other" xlink:type="simple">Song, C.Y., Ghafoor, K., Ghafoor, H.U., et al. (2016) Cytochrome P450 1B1 Contributes to the Development of Atherosclerosis and Hypertension in Apolipoprotein E-Deficient Mice. Hypertension, 67, 206-213. https://doi.org/10.1161/HYPERTENSIONAHA.115.06427</mixed-citation></ref></ref-list></back></article>